This January we were treated to a mix of novel psychedelic trials and an unusually large amount of re-analyses of earlier studies. Ibogaine was researched for traumatic brain injury (TBI) in veterans, DMT was researched in two separate trials, and psilocybin for chronic cluster headaches (CCHs) was put to the test. The re-analyses investigated the effects of psychedelics in the brain…
